NR2F6 and cancer: Expression data for 38 cancer types were obtained as well as DSS data from corresponding samples, and higher expression of NR2F6 in GBMLGG, LGG, KIRC, SKCM, SKCM, CM-M, MESO, PCPG, and ACC was associated with worse DSS, and higher expression in BLCA and OV was associated with better DSS (Fig 2B).